Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/10/20
End: 01/02/24
Due: 01/02/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic Dermatitis | NCT04313400 | Amytrx Therapeutics, Inc. | user2@example.com | None | 2020-03-10 | 2024-01-02 | 2025-01-02 | - | - | 2025-07-14 |